CATALOGO DEI PRODOTTI DELLA RICERCA

RIGHI, Elda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.693
NA - Nord America 3.498
EU - Europa 2.656
SA - Sud America 602
AF - Africa 64
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 10.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.399
SG - Singapore 1.594
CN - Cina 1.152
BR - Brasile 532
HK - Hong Kong 509
RU - Federazione Russa 451
FR - Francia 440
IE - Irlanda 402
IT - Italia 358
GB - Regno Unito 241
DE - Germania 215
SE - Svezia 155
UA - Ucraina 125
VN - Vietnam 113
FI - Finlandia 102
KR - Corea 88
CA - Canada 61
JP - Giappone 55
AT - Austria 43
IN - India 29
BD - Bangladesh 25
AR - Argentina 24
ES - Italia 22
IQ - Iraq 20
MX - Messico 18
BE - Belgio 17
NL - Olanda 16
ID - Indonesia 15
TG - Togo 15
TR - Turchia 15
AU - Australia 14
CZ - Repubblica Ceca 13
PL - Polonia 12
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
EC - Ecuador 9
PY - Paraguay 9
ZA - Sudafrica 9
MA - Marocco 8
SA - Arabia Saudita 8
UZ - Uzbekistan 7
CH - Svizzera 6
KE - Kenya 6
TN - Tunisia 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
KZ - Kazakistan 4
LT - Lituania 4
PE - Perù 4
PT - Portogallo 4
RO - Romania 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
BY - Bielorussia 3
CO - Colombia 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
MY - Malesia 3
OM - Oman 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BZ - Belize 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
TZ - Tanzania 2
AQ - Antartide 1
BF - Burkina Faso 1
BH - Bahrain 1
BI - Burundi 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
JO - Giordania 1
Totale 10.517
Salva come PNG Salva come JPEG
Città #
Singapore 686
Chandler 517
Hong Kong 505
Dallas 457
Jacksonville 455
Dublin 393
Beijing 206
Southend 201
Ashburn 191
Verona 182
Lawrence 165
Princeton 165
The Dalles 114
Wilmington 112
Nanjing 95
Redmond 90
Shenyang 87
Helsinki 77
New York 74
Jinan 68
Sindelfingen 60
Tokyo 52
Ann Arbor 50
Munich 43
Tianjin 42
Zhengzhou 41
Hebei 38
São Paulo 38
Changsha 37
Columbus 37
Ho Chi Minh City 36
Nanchang 35
Hangzhou 34
Santa Clara 32
Toronto 30
Nuremberg 28
San Francisco 27
Vienna 27
Jiaxing 26
Haikou 25
Guangzhou 23
Seattle 23
Ningbo 22
Council Bluffs 21
Taizhou 20
Los Angeles 19
Belo Horizonte 17
Hanoi 17
Milan 17
Redwood City 17
Dong Ket 16
Rio de Janeiro 16
Washington 16
Boardman 15
Brussels 15
Lanzhou 15
Lomé 15
Chicago 14
Norwalk 14
Turku 13
Frankfurt am Main 12
Brno 11
Shanghai 11
Campinas 10
Jakarta 10
Warsaw 10
Bologna 9
Brooklyn 9
Fuzhou 9
Houston 9
Lappeenranta 9
London 9
Madrid 9
Montreal 9
Amsterdam 8
Brasília 8
Lahore 8
Ottawa 8
Salvador 8
Volta Redonda 8
Atlanta 7
Baghdad 7
Dhaka 7
Fairfield 7
Goiânia 7
Seoul 7
Taiyuan 7
Tashkent 7
Blacksburg 6
Boston 6
Boydton 6
Canberra 6
Clearwater 6
Joinville 6
Moscow 6
Porto Alegre 6
Sorocaba 6
Berlin 5
Curitiba 5
Dearborn 5
Totale 6.232
Salva come PNG Salva come JPEG
Nome #
Assessment of COVID-19 progression on day 5 from symptoms onset 132
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli 129
European Society of Clinical Microbiology and Infectious Diseases/European Committee on infection control clinical guidelines on pre-operative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery 120
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 115
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage 112
Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations 109
Hospital hygiene and infection prevention and control in Italy: State of the art and perspectives 108
A Digital Approach to Improve Infection Screening Among Solid Organ Transplant Candidates 105
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 104
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 104
A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine 103
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency 99
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 97
Antibiotics for pulmonary infections: an overview 95
Methods for quantitation of leukocyte chemotaxis and fugetaxis 92
Antiretroviral blood levels in HIV/HCV‐coinfected patients with cirrhosis after liver transplant: a report of three case 89
Antimicrobial treatment challenges in the era of carbapenem resistance. 89
Physical activity: Benefits and challenges during the COVID-19 pandemic 88
Antimicrobial use and resistance among Gram-negative bacilli in an Italian intensive care unit (ICU) 87
Issues in the Management of Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients in the Intensive Care Unit: A Role for Isavuconazole 83
Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities 83
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies 81
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 81
Antimicrobial resistance and treatment: an unmet clinical safety need 80
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs Useful for clinicians? 79
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 78
High maraviroc plasma concentration and severe polyneuropathy in a HIV-positive kidney transplant recipient 77
Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections. 75
Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report 75
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts 74
Infezione da Nocardia: casistica dell’Ospedale di Circolo di Varese, 2001-2012 74
Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study 74
Antimicrobial prophylaxis in minor and major surgery 73
Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis 73
Carbapenemase-producing Enterobacteriaceae in transplant patients 72
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol 70
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 70
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: Current applications and future perspectives 70
Candidaemia in internal medicine departments: the burden of a rising problem 69
Serological and T Cell Responses After Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 69
Immunological profiles of HIV-positive recipients of liver transplant 69
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 68
How to manage Pseudomonas aeruginosa infections 68
Bloodstream infections in the intensive care unit 67
Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality 67
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 67
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 64
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp. 64
Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit 64
X4 human immunodeficiency virus type 1 gp120 down-modulates expression and immunogenicity of codelivered antigens 64
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals 64
Linezolid in the treatment of Gram-positive prosthetic joint infections 63
Ceftaroline and ceftaroline-avibactam 63
Persistent hematogenous dissemination in pulmonary P. jiroveci infection 63
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. 62
Soft-tissue infection with Absidia corymbifera and kidney complications in an AIDS patient 62
HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection 62
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 62
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections 62
Fungal pulmonary infections: the conservative approach, 62
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 62
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 62
Dalbavancin in the treatment of acute bacterial skin and skin structure and other infections: a safety evaluation 60
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma 60
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease 59
R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes 59
Delafloxacin for the treatment of respiratory and skin infections 59
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 59
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin 59
Comparison of clinical characteristics of tuberculosis between two age groups at an Italian Tertiary Hospital 59
Multidrug-resistant klebsiella pneumoniae: Challenges for treatment, prevention and infection control 59
Gut Microbiome Disruption Following SARS-CoV-2: A Review 58
Management of vertebral osteomyelitis in an 8-year period: the UDIPROVE (UDIne PROtocol on VErtebral osteomyelitis) 58
Evaluation of antigen-specific T-cell responses with a miniaturized and automated method 57
Report of Four Simultaneous Pancreas-Kidney Transplants in HIV-Positive Recipients with Favorable Outcomes 57
Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects 57
Invasive Candida infections in liver transplant recipients: clinical features and risk factors for mortality 57
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis 56
Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer 56
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 56
Encefaliti erpetiche negli anni 2001 – 2011 presso l’Ospedale di Circolo di Varese 56
Nuove Diagnosi di Infezione da HIV Presso la Clinica di Malattie Infettive e Tropicali di Varese nel Periodo 2009-2011 56
New therapeutic options for skin and soft tissue infections 56
Current and future treatment options for infections caused by multidrugresistant Gram-negative pathogens 55
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections 55
Prosthetic joints: shining lights on challenging blind spots 55
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems 55
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 55
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments 55
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery 54
Uso di daptomicina nelle infezioni gravi da Enterococcus spp 54
Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? 54
Transient HBcAb Seroconversion in Kidney Transplant Recipients of HBcAb-Positive Donors 54
Outcome del Paziente HIV-Positivo Trapiantato di Rene e Rene-Pancreas 54
Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering 54
New Antibiotics for Pneumonia 54
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 53
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review 53
Tigecycline use in serious nosocomial infections: a drug use evaluation 53
Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit 53
Totale 7.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.969
article - articoli 48.006
book - libri 0
conference - conferenze 1.936
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.027
Totale 103.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021651 0 0 16 145 135 128 7 8 15 17 131 49
2021/2022923 52 155 20 11 14 10 18 83 47 15 117 381
2022/20231.876 181 119 233 306 158 495 29 98 196 9 35 17
2023/20241.097 45 68 125 130 80 211 58 114 6 22 153 85
2024/20253.574 248 183 77 585 200 115 229 179 538 390 228 602
2025/20261.614 728 537 349 0 0 0 0 0 0 0 0 0
Totale 10.883